[Experiences with vincristine sulfate in the therapy of malignant tumors].
D000505:Alopecia / Q000139:chemically induced; D003248:Constipation / Q000139:chemically induced; D004351:Drug Resistance; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000188:drug therapy; D007970:Leukopenia / Q000139:chemically induced; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy*; D013431:Sulfates / Q000627:therapeutic use; D014750:Vincristine / Q000009:adverse effects / Q000627:therapeutic use*
D013431:Sulfates; D014750:Vincristine
Erfahrungen mit Vincristinsulfat bei der Behandlung maligner Tumoren.